Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fetal cardiac changes in diabetic pregnancy: insulin versus insulin + metformin
IRCT20140525017827N14Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Diabetes mellitus in pregnancy and gestational diabetes mellitus (GDM) comparing Insulin alone with Insulin + metformin (2 arms). Primary endpoints: Fetal echocardiographic findings, Birth weight and 4 more. Started Dec 2024; status: completed.
02
Drugs
human insulinmetformin
03
Conditions
Diabetes mellitus in pregnancygestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on IRCT20140525017827N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140525017827N14.